Full name
NAMEDYCYNE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.91.Z - Intermediary retail sale, non-specialized
46.19.Z - Activity of agents involved in wholesale trade of non-specialized goods
46.42.Z - Wholesale trade of clothing and footwear
46.90.Z - Non-specialized wholesale trade
47.61.Z - Retail sale of books
47.62.Z - Retail sale of newspapers, periodicals, and paper articles
47.71.Z - Retail sale of clothing
47.72.Z - Retail sale of footwear and leather goods
47.79.Z - Retail sale of used products
47.89.Z - Retail trade
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,1 | 0,2 | 0,3 | 74,4 |
EBITDA | 0,1 | 0,2 | 0,4 | 68,2 |
Short time liabilities | 0,3 | 0,3 | 0,3 | -4,9 |
Equity capital | 0,2 | 0,4 | 0,7 | 84,6 |
Operating profit (EBIT) | 0,1 | 0,2 | 0,3 | 73,7 |
Assets | 0,5 | 0,7 | 1 | 40,5 |
Net profit (loss) | 0,1 | 0,2 | 0,3 | 74,8 |
Cash | 0,1 | 0 | 0,1 | 387,4 |
Liabilities and provisions for liabilities | 0,3 | 0,3 | 0,3 | -4,9 |
Net income from sale | 3,3 | 4,7 | 5,7 | 21,4 |
Working assets | 0,5 | 0,7 | 1 | 42,5 |
Depreciation | 0 | 0 | 0 | -20 |
% | % | % | p.p. | |
Profitability of capital | 58,1 | 48,4 | 45,8 | -2,6 |
Equity capital to total assets | 37,9 | 50,7 | 66,6 | 15,9 |
Gross profit margin | 3,5 | 4,1 | 5,9 | 1,8 |
EBITDA Margin | 3,8 | 4,5 | 6,2 | 1,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 33 | 27 | 21 | -6 |
Current financial liquidity indicator | 1.6110963821411133 | 1.9980123043060303 | 2.9938595294952393 | 1 |
Net dept to EBITDA | 0.17715035378932953 | 0.622669517993927 | 0.07785231620073318 | -0,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane